Home › Funds › Parkman Healthcare Partners LLC › JAZZ
Parkman Healthcare Partners LLC position in JAZZ
JAZZ PHARMACEUTICALS PLC · Health Care
Parkman Healthcare Partners LLC reported holding 50,066 shares of JAZZ (JAZZ PHARMACEUTICALS PLC) in its Q3 2026 13F filing — a position valued at US$11.6M, representing 1.05% of its reported portfolio and ranking #40 among its reported holdings. Parkman Healthcare Partners LLC has disclosed JAZZ holdings in 3 of the last 9 reported quarters, going back to Q3 2024.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Parkman Healthcare Partners LLC's JAZZ position evolved
Parkman Healthcare Partners LLC first disclosed a stake in JAZZ in Q3 2024 at 72,256 shares (US$8.1M). The position peaked in Q3 2026 at 50,066 shares, worth US$11.6M. Across 3 filings, Parkman Healthcare Partners LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 50,066 shares valued at US$11.6M. Notable position changes include a 48% trim in Q4 2024 (shares were roughly flat over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 72.26K | $8.05M | New |
| Q4 2024 | 37.75K | $4.65M | Reduce |
| Q3 2026 | 50.07K | $11.59M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About JAZZ and 13F data
JAZZ (JAZZ PHARMACEUTICALS PLC) is a Health Care company. 41 other funds we track also report a position in JAZZ — the largest reported positions include FULLER & THALER ASSET MANAGEMENT, INC. (US$323.8M), MILLENNIUM MANAGEMENT LLC (US$184.1M), Boston Trust Walden Corp (US$98.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding JAZZ
- FULLER & THALER ASSET MANAGEMENT, INC. 1.40M sh · $323.77M · Q3 2026
- MILLENNIUM MANAGEMENT LLC 763.88K sh · $184.07M · Q2 2026
- Boston Trust Walden Corp 424.57K sh · $98.30M · Q3 2026
- Sofinnova Investments, Inc. 422.38K sh · $97.79M · Q3 2026
- GMT CAPITAL CORP 412.80K sh · $95.57M · Q3 2026
More on Parkman Healthcare Partners LLC
FAQ
How long has Parkman Healthcare Partners LLC held JAZZ?
Parkman Healthcare Partners LLC has disclosed JAZZ holdings in 3 of the last 9 reported quarters, going back to Q3 2024.
What is Parkman Healthcare Partners LLC's current position in JAZZ?
As of Q3 2026, Parkman Healthcare Partners LLC holds 50.07K shares of JAZZ (JAZZ PHARMACEUTICALS PLC), valued at $11.59M, representing 1.05% of its reported portfolio and ranking #40.
Has Parkman Healthcare Partners LLC been buying or selling JAZZ?
In the latest 13F filing (Q3 2026), Parkman Healthcare Partners LLC newly opened its position in JAZZ. The position peaked in Q3 2026 at 50.07K shares.
Which other funds hold JAZZ?
Other major institutional holders of JAZZ include FULLER & THALER ASSET MANAGEMENT, INC., MILLENNIUM MANAGEMENT LLC, Boston Trust Walden Corp, among 41 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.